Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Midcap Core Guggenheim | CZA | Jan 13, 2025 | 103.53 | +1.35 |
Midcap Dividend Wisdomtree | DON | Jan 13, 2025 | 50.41 | +1.27 |
Midcap Earnings Wisdomtree | EZM | Jan 13, 2025 | 62.13 | +0.70 |
Midcap ETF Vanguard | VO | Jan 13, 2025 | 264.10 | +0.49 |
MidCap Financial Investment | MFIC | Jan 13, 2025 | 13.22 | +0.53 |
Midcap Growth Alphadex First Trust | FNY | Jan 13, 2025 | 80.20 | +0.10 |
Midcap Growth ETF Vanguard | VOT | Jan 13, 2025 | 256.16 | +0.01 |
Midcap Value Alphadex First Trust | FNK | Jan 13, 2025 | 53.53 | +1.48 |
Midcap Value ETF Vanguard | VOE | Jan 13, 2025 | 160.67 | +0.95 |
Middleby | MIDD | Jan 13, 2025 | 136.71 | +1.64 |
Middlefield Banc | MBCN | Jan 13, 2025 | 25.13 | +1.86 |
Middlesex Water | MSEX | Jan 13, 2025 | 49.30 | +0.88 |
Midland States Bancorp | MSBI | Jan 13, 2025 | 22.99 | +1.41 |
Midland States Bancorp Pref A | MSBIP | Jan 13, 2025 | 24.99 | -0.16 |
MidWestOne Financial Group | MOFG | Jan 13, 2025 | 27.96 | +1.19 |
Milestone Pharmaceuticals | MIST | Jan 13, 2025 | 1.97 | -5.29 |
Milestone Scientific | MLSS | Jan 13, 2025 | 1.08 | -8.47 |
Mill City Ventures | MCVT | Jan 13, 2025 | 3.20 | -0.93 |
Millennium Group International | MGIH | Jan 13, 2025 | 1.73 | +10.19 |
Miller Industries | MLR | Jan 13, 2025 | 63.85 | +0.92 |
MillerKnoll | MLKN | Jan 13, 2025 | 21.65 | +1.07 |
Millicom International Cellular | TIGO | Jan 13, 2025 | 24.14 | +1.26 |
MiMedx Group | MDXG | Jan 13, 2025 | 8.56 | -1.04 |
MIND C.T.I. | MNDO | Jan 13, 2025 | 2.04 | +0.99 |
Mind Technology | MIND | Jan 13, 2025 | 7.78 | +12.43 |
MindMed | MNMD | Jan 13, 2025 | 6.50 | -6.28 |
Minerals Technologies | MTX | Jan 13, 2025 | 73.54 | +2.21 |
Mineralys Therapeutics | MLYS | Jan 13, 2025 | 9.36 | -5.17 |
Minerva Neurosciences | NERV | Jan 13, 2025 | 2.12 | -2.53 |
Ming Shing Group | MSW | Jan 13, 2025 | 7.91 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.